ebook img

Synthesis Characterization and Antibacterial, Antifungal Activity of N-(Benzyl Carbamoyl or ... PDF

21 Pages·2015·1.77 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Synthesis Characterization and Antibacterial, Antifungal Activity of N-(Benzyl Carbamoyl or ...

HindawiPublishingCorporation InternationalJournalofMedicinalChemistry Volume2013,ArticleID436397,20pages http://dx.doi.org/10.1155/2013/436397 Research Article Synthesis Characterization and Antibacterial, Antifungal Activity of N-(Benzyl Carbamoyl or Carbamothioyl)-2-hydroxy Substituted Benzamide and 2-Benzyl Amino-Substituted Benzoxazines TysonBelz,SalehIhmaid,JasimAl-Rawi,andStevePetrovski SchoolofPharmacyandAppliedScience,LaTrobeUniversity,P.O.Box199,Bendigo,UIC3552,Australia CorrespondenceshouldbeaddressedtoJasimAl-Rawi;[email protected] Received17June2013;Revised8August2013;Accepted11August2013 AcademicEditor:ArmandoRossello Copyright©2013TysonBelzetal.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense, whichpermitsunrestricteduse,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited. NewN-(benzylcarbamothioyl)-2-hydroxysubstitutedbenzamides13,20,and21weresynthesizedusingsodiumbicarbonateand benzylaminewith2-thioxo-substituted-1,3-benzoxazines6,10a,b,11c,and12a–n.The2-thioxo-substituted-1,3-oxazines6,10a- b,11d12a–n,and26wereconvertedtothecorresponding2-methylthio-substituted-1,3-oxazines14a–land24whichwerethen convertedto2-benzylamino-substituted-benzoxazines15a–ibyrefluxingwithbenzylamine.Products15a,b,e,f,andgwerealso synthesizedbyboilingthecorrespondingN-(benzylcarbamothioyl)-2-hydroxysubstitutedbenzamides13a,b,f,l,andminacetic acid.2-Oxo-substituted-1,3-benzoxazines22and25werepreparedbytreatingthecorresponding2-methylthio-substituted-1,3- oxazines14and24withdiluteHCl.TheN-(benzylcarbamoyl)-2-hydroxysubstitutedbenzamide23wassynthesizedfromthe 1 13 reactionof2-oxo-substituted-1,3-benzoxazine22withbenzylamine.ThenewproductswerecharacterizedusingIR, H,and C NMRinadditiontomicroanalysis.Selectedcompoundsweretestedinvitroforantibacterialandantifungiactivityandthemost activecompoundswerefoundtobethe4-(substituted-benzylamino)-2-hydroxybenzoicacids9aandd(M.chlorophenolicum,MIC 50and25𝜇gmL−1,resp.),N1,N3-bis(benzylcarbamothioyl)-4,6-dihydroxy-substitutedphthalamides20aand20c(B.subtilisMIC 12.5,50𝜇gmL−1,resp.)and21(M.chlorophenolicum,MIC50𝜇gmL−1). 1.Introduction The Topliss method [14] was used in the optimization ofsalicylicacidderivativesforpotentialuseasantibacterial Thesearchfornewantibacterialcompoundsisachallenging agents. The employment and analysis of physicochemical task as bacteria are continuously developing resistance to parameters and molecular electronic surfaces which high- antimicrobial compounds; however, infections due to such lighttheelectronic,lipophilic,andstericfeaturesmaybeuse- bacterialstrainsareinfrequentalthoughpotentiallyfatal[1– fulguidelinesinthecontinuoussearchfornew,moreeffective 3].Thisongoingproblemhasresultedinthesearchfornewer, 3-amino-salicylic acid analogs. The synthesis of the urea or moreeffectiveantibacterialcompounds[1–3]. thioureaproduct(3,Scheme1)waspreviouslyachievedfrom Urea, thiourea 3 (X=O or S), and benzo-1,3-oxazine thereactionofbenzoylisocyanateorbenzoylisothiocyanate1 compounds5and6(Scheme1)havebeenshowntopossess (X=OorS,resp.)withamines2[15–17]. antibacterial and antifungal properties [4–11]. The benzyl thiourea analogue 3 has been reported to show activity The substitution R on the aromatic ring could be alkyl, againstGram-positivebacteria[12]. alkoxy, –OC=OCH3 in positions 2, 3, 4, 5, and 6, and the TheN-benzoyl-2-hydroxybenzamides[13]areimportant R1-N-R2inproduct3couldbealiphatic,aromatic,orcyclic pharmacophores for antibacterial activity in which the 2- aminesubstitutions.Limitationassociatedwiththismethod hydroxygroup(hydrogenbondingdonor)contributestothe is that R, the substitution on the aromatic ring, cannot be activity, the imide linker (preferred) or urea linker retains –OH or RN–, which is desirable for antimicrobial activity, activityandfreeNHisrequiredforhighactivity. particularlythehydroxygroup[18]. 2 InternationalJournalofMedicinalChemistry Furthermore, the synthesis of 2-amino-substituted-1,3- l R = 7-OH,-8-CH3, and m R = 8-OH), 18, and 19 were benzoxazine 5 was achieved through the reaction of the synthesized from the reaction of the substituted 2-hydroxy correspondingamine2withethyl2-cyanobenzoate4[19–21]. benzoicacidwithfreshlypreparedPh3P(SCN)2 (Schemes2 However,againthelimitationinthismethodisthattheRin and3)followingthereportedconditions[22,34]withsome product5cannotbe–OHor–NH2. modifications(seeExperimental).Itisworthnotingthatthe Thereactionofsubstituted2-thio-1,3-benzoxazine-4-one reaction of 4-benzylideneamino-2-hydroxybenzoic acid 8d 6 (Scheme1) with primary and secondary amines showed formedthecorresponding7-(benzylidene)amino-2-thio-1,3- considerableinterestintheliterature. benzoxazineswhichwerehydrolysedduringtheisolationof The secondary amine 2 (dimethyl, diethyl, and cyclic the product and gave 7-amino-2-thio-1,3-benzoxazines 10b. amines) reaction with 2-thioxo-2,3-substituted 1,3-benzo- However, the reaction of 4-amino-2-hydroxybenzoic acid 7 xazin-4-one 6 gave only 2-amino-substituted-1,3-benzo- withthefreshlypreparedPh3P(SCN)2 failedtoproducethe xazine5[19,20,22,23].Reactionswithprimaryamineslead expectedproduct10bhowevergaveacomplex,unidentifiable to the opening of the oxazine ring and produce thiourea moleculecontainingatriphenylphosphenegroupattachedto typeanalogues(compound3R=2-OHandR1NR2=–HN- theoxazineproduct. alkyl)whilewithNH2 CH2Phgave3R=2-OHandR1NR2 7-(Substituted benzylamino)-2-thioxo-2,3-dihydro-4H- =NHCH2Phmixedwith2-(benzylamino)-4H-benz[e]-1,3- 1,3-benzoxazin-4-one 11a–c were synthesized from the oxazin-4-one(5R=HandR1NR2=–NHCH2Ph[19,20].The reaction of 4-(substituted-benzylamino)-2-hydroxybenzoic abovereactionproducedlowyieldsoramixtureofproducts acids 9a–c with the freshly prepared Ph3P(SCN)2 [22, 32] 13aand15a(Scheme2)whichwasdifficulttoseparate. (Scheme2). The structures of the new products 11a–c were 1 13 In this work, we developed simple general procedures confirmedusing H,and CNMRandmicroanalysis. for the synthesize of N-(benzyl carbamothioyl)-2-hydroxy- Similarly,thesubstituted-2-thioxo-1,3-benzoxazin-4-one benzamides13,20,and21,N-(benzylcarbamoyl)-2-hydroxy- 6 and 12b–n prepared using a previously reported [22, substituted-benzamides 23, and 2-(benzyl amino)-sub- 23, 33] method gave products with identical physical and stituted-1,3-benzoxazin-4-one 15 and 26. The antibacterial spectroscopicdata. andantifungalactivitywasevaluatedforanumberofthese The benz-bis-(1,3-oxazine) 18a–c and 19 were prepared products with the intension of producing novel products from the reaction of dihydroxy-dicarboxybenzoic acids that can be used to eliminate problematic bacteria in the 16a–cand17withthefreshlypreparedPh3P(SCN)2 [22,32] environmental and medical settings. These compounds according to the previously reported method [34] for the couldpotentiallyresultinnovelantibiotic. synthesisof18cwithsomemodificationtoimprovetheyield. The structures of the new dibenzoxines products 18a.b 1 13 and 19 were confirmed using H and CNMR and micro- 2.ResultsandDiscussion analysis(Scheme4). 2.1.Chemistry 2.1.3. Synthesis of the 2-Methylthio-substituted-1,3-oxazines. 2.1.1.SynthesisofSubstituted2-HydroxyAromaticCarboxylic 2-Methylthio-substituted-1,3-oxazines14a–i(aR=H,bR= Acids. 5-Substituted-4,6-dihydroxybenzene-1,3-dicarboxylic 8-CH3,cR=8-Ph,dR=7-OCH3,eR=7-OCH2CH3,f R acids 16a–c, and 2,3-dihydroxybenzene-1,4-dicarboxylic =7-OH,gR=7-OH,-8-CH3,hR=AcNH,andIR=NH2) acid17werepreparedbycarboxylationof2-substituted-1,3- and24werepreparedbythereactionofCH3Iinthepresence hydroxy-benzene and 1,2-dihydroxy-benzene, respectively, of NaHCO3 with substituted-1,3-oxazines 6, 10a,b, 11c, and according to the previously reported method [24]. Comp- 12 (a R = 8-CH3, b R = 8-Ph, e R = 7-OCH2CH3, h R = 7- ound 7 was selectively acetylated in the presence of NaOH OCH3,kR=7-OH,andlR=7-OH,-8-CH3)accordingtothe andaceticanhydridewiththereactionmaintainedatpH6-7 previously reported procedure [35]. Physical properties, IR, in accordance with the reported procedure [25–27] to give 1HNMR,and13CNMR,collectedforproducts14a–Iwere theacid8aanexcellentyield(82%)(Scheme2). foundtobeidenticaltothereporteddata[35].Thestructures Allowingcompound7toreactwithsubstitutedbenzalde- ofnewproduct,14h,i,and24wereconfirmedwithanalysis hyde gave the corresponding Schiff base 8b-c (Scheme2) oftheIR,1H,and13CNMRdata. [28–33].ReductionofSchiffbase8b-cwithsodiumborohy- Compounds14a–iand24were used inthesynthesisof dride gave 4-(substituted-benzylamino)-2-hydroxybenzoic compounds15a–Iand26withnofurtherpurification. acids 9a–c with high yield (73–85%). The structures of 1 the prepared acids were confirmed using mp, IR, H, and 13 2.1.4. Synthesis of Benzyl Thiourea 13a–q, 20a, c, and 21. CNMRwhichwasingoodagreementwiththepreviously Initially, the equimolar reaction of compound 6 with ben- reportedphysicalandspectroscopydata[26–28]. zylamine in dioxane was repeated according to the earlier reported method [19, 20], in which the mixture that was 2.1.2.SynthesisofSubstituted2-Thio-substituted-benzoxazines. refluxedfor4hoursgave13aandwasa46%yield(Scheme3). The 2-thio-substituted-1,3-benzoxazines 6, 10, 11, 12 (a R However,whenthereactionwascarriedoutusingsolvent = 8-CH3, b R = 8-Ph, c R = 6-Br, d R = 6-OCH2CH3, e free conditions, excess benzylamine was added directly to R = 7-OCH2CH3, f R = 8-OCH2CH3, g R = 6-OCH3, h powered2-thio-1,3-benzoxazine6andthemixturewasleftat R = 7-OCH3, i R = 8-OCH3, j R = 6,8-I, k R = 7-OH, roomtemperaturefor2days,thebenzylthioureaproduct13a InternationalJournalofMedicinalChemistry 3 R 3 R 3 R 4 2 1 4 2 R NH 1 5 1 N=C + R2 5 1 HN N R 6 =X 6 2 1 O 2 O X 3 R R OCN 1 R O N OEt 4 + 2 R2 O N O S O N + 2 H 5 O 6 Scheme1:Previoussynthesisofureaorthiourea3(X=OorS)and2-aminobenzo1,3-oxazine5. H2N OH R OH R1 O S i ii O O 8a, d NH OH OH O 7 8 10 aR=AcNH aR1=AcNH bR=phenyl-C=N bR1=NH2 cR=2-Hydroxy-phenyl-C=N dR=3-Ethoxy-2-hydroxy-phenyl-C=N R2 8b–ieii R2 R3 R1 R3 R1 iv HN OH HN O S O NH 9 11 OH O aR1=R2=R3=H aR1=R2=R3=H bR2=R3=H, R1=OH bR2=R3=H, R1=OH cR1=OH,R2=OEt,R3=H cR1=OH,R2=OEt,R3=H Scheme2:Synthesisof7-N-substituted-1,3-oxazines10-11startingfrom2-hydroxy-substitutedbenzoicacids8and9.Reactionconditions: (i) compound a (Ac)2O, b PhCH=O, c 2-hydroxy-C6H4-CH=O, and d 3-ethoxy-2-hydroxy-C6H3-CH=O, (ii) Ph3P(SCN)2 in CH2Cl2, (iii)NaBH4,and(iv)Ph3P(SCN)2inCH2Cl2. 4 InternationalJournalofMedicinalChemistry R 8 1 3 8󳰀 O S R OH 7 4 7󳰀 9󳰀 8a 2 NaHCO3:PhCH2NH2 2 2󳰀 4󳰀 6 4a 4 NH 1:1 MeOH:H2O 5 1 1󳰀 HN 3󳰀 HN 6󳰀 5 6 5󳰀 O O S 6,10a–b,11c, and12a–m 13 a:R=H (75%) j:R=3-OCH3 (82%) b:R=3-CH3 (79%) k:R=3,5-I (75%) c:R=3-Ph (80%) l:R=4-OH (87%) d:R=5-Br (82%) m:R=4-OH-3-CH3 (78%) NaHCO3: CH3I Acetic acid: reflux2hrs e:R=5-OCH2CH3 (87%) n:R=3-OH (72%) f:R=4-OCH2CH3 (73%) o:R=NH2 (47%) g:R=3-OCH2CH3 (69%) p:R=AcNH (78%) h:R=5-OCH3 (69%) q:R=4[3-OEt,2-OH(C6H3-)]NH- (70%) i:R=4-OCH3 (69%) 6󳰀 5󳰀 7󳰀 2󳰀 R O S R O HN 4󳰀 CH 3 PhCH NH 3󳰀 2 2 Dioxane N N O O 14a–i 15 From13to15 From14to15 15a:R=H (75%) 15a:R=H (75%) 15f:R=7-OH (77%) 15b:R=8-CH3 (67%) 15b:R=8-CH3 (72%) 15g:R=7-OH,-8-CH3 (74%) 15e:R=7-OCH2CH3 (61%) 15c:R=8-Ph (65%) 15h:R=AcNH (47%) 15f:R=7-OH (67%) 15d:R=7-OH3 (83%) 15i:R=NH2 (47%) 15g:R=7-OH-8-CH3 (70%) 15e:R=7-OCH2 CH3 (80%) Scheme3:SynthesisofN-(benzylcarbamothioyl)-2-hydroxy-substitutedbenzamide13,substituted2-benzylamino-1,3-benzoxazines15. had decreased yield (19%), and none of the cyclic analogue WithslightmodificationtotheprocedureB,byaltering 15a could be isolated. When 2-thio-1,3-benzoxazine 6 was the ratio of benzylamine to starting material (3:1) and the allowed to react with excess benzylamine (4-fold) and the reaction time to 16 hours, the bis-oxazines 18a,c and 19 mixturewasthenheatedtorefluxindioxanefor2hours,the were found to react in a similar fashion to give substituted openproduct13awasagainisolatedin18%yield. bis(benzyl carbamothioyl) analogues 20a,c (yield 63, 49%) To overcome this low yield and possible mixture for- and21(yield63%)(Scheme4). mation, the reaction procedure was modified in which the The previously prepared N-(benzyl carbamothioyl)-2- benzoxazines 6, 10a-b, 11d, and 12b–m were mixed with hydroxybenzamide13awascharacterizedbycomparisonof NaHCO3 andsuspendedin1:1mixtureofmethanol,water 1 13 ∘ its physical data (mp, IR, H and C NMR spectra) with andthemixturewasthenheatedto40 Cforafewminutes. values found in the literature [12, 19, 20]. The structures of Excess(1.5-fold)benzylaminewasaddeddropwiseatroom newbenzylthioureacompounds13b–q,20a,c,and21were temperature and left stirring for 4 hours. Products 13a– 1 13 q was isolated according to the general procedure B (see confirmed using IR, H NMR and C NMR spectroscopy 1 Experimental)andtheyieldweremoderatetohigh(69–87%) andmicroanalysis.The HNMRandIRspectraalsoshoweda (Scheme3). highcorrelationwiththepreviouslypreparedbenzylthiourea InternationalJournalofMedicinalChemistry 5 R R R HO OH S O O S HO OH H H H H HO OH i HN NH ii N N N N O O O O Ph S O O S Ph 16a–c 18a–c aR=H 20a, c bR=OH OH OH S cR=CH3 OH H H N N OH HO S O HN O i ii H H OH O S N N O HN O O NH Ph S O Ph 17 19 O 21 Scheme4:Synthesisofsubstituted-N,N-bis(benzylcarbamothioyl)-dihydroxy-isoandtetraphthalamides20a,c,and21.Reactionconditions: (i)Ph3P(SCN)2inCH2Cl2and(ii)NaHCO3,PhCH2NH2. 1 󸀠 13a [19, 20]. In the H NMR spectra, the CH2, H-5 of the literature[19,20].Thestructuresofnew2-benzylamino-1,3- benzyl amine in compounds 13a–q, 20a,c, and 21 appeared benzoxazinecompounds15b–gwereconfirmedusingIR,1H as a doublet at ∼𝛿 4.9ppm and the 4󸀠-NH, appeared as a NMR,and13CNMRspectroscopyandmicroanalysis.Inthe tripletat∼𝛿11.0ppminallcases.Assignmentofthecarbon- 1 HspectratheCH2ofthebenzylamineappearsasadoublet 13 chemical shifts was made using the previous reported at ∼𝛿 4.5ppm. The previously analysed 1H and 13C NMR 1 13 chemicalshiftsof 13a[19,20].The Hand CNMRspectra spectra of the parent 2-methylthio-1,3-benzoxazines 14 [35] of the parent 2-thioxo-2H-benz[e]-1,3-oxazin-4(3H)-one 12 wereusedtoaidintheanalysisofthenewproducts15b–gs. were also used to aid with structural identification. The 1 13 simulated H and C NMR spectra using ChemDraw V12 2.1.6.Synthesisof2-Oxo-substituted-benzoxazines22a–hand ultra were also used as references to aid the analysis of the 1 13 25. 2-Methylthio-substituted-benzoxazines 14a, b, and d–g observed Hand CNMRspectraofthenewproducts. wereallowedtoreactwith10%HClaccordingtothegeneral procedureEandgave2-dione-1,3-benzoxazines22a–hwith good to excellent yield (Scheme5); however, product 22h was produce if 40% HCl was used in the hydrolysis of 2.1.5.Synthesisof2-Benzylamino-(substituted)-benz-1,3-ox- 14h. Similarly, the 2,8-dioxo product 25 was prepared from azines15. Asmentionedearlierthereactionofthe2-thio-1,3- the hydrochloric acid hydrolysis of the corresponding 2,8- benzoxazine6withaprimaryaminedidnotconsistentlygive dimethylthio-analogue24(Scheme5). thecyclicproduct13a[19,20]. The reaction of 2-methylthio-(substituted)-1,3-benzoxa- zines14(aR=H,bR=8-CH3,cR=8-Ph,dR=7-OCH3,e 2.1.7.SynthesisofSubstituted-N-(benzylcarbamoyl)-2-hydro- R=7-OCH2CH3,fR=7-OH,gR=7-OH,-8-CH3,andhR= xybenzamides 23a–g. The synthesis of the substituted- AcNH-)and24withexcess(5-fold)benzylamineaccording N-(benzyl carbamoyl)-2-hydroxybenzamides 23a–g was tothegeneralprocedureCgave2-benzylamino-substituted- achieved using the reaction of the relevant benzoxazine-2, 1,3-benzoxazines15a–hand26withmoderatetohighyields 4-di-one 22a–h with excess benzylamine in dioxane with 62–83%(Schemes3and5). refluxedaccordingtothegeneralprocedureF. Thereactionofbenzylaminewith2-methylthio-benzoxa- zinetookplacewithnotraceofthethioureaanalogue13. Structure Elucidation of Substituted-N-(benzyl carbamoyl)- Followingtheirsuccessfulsynthesis,manyoftheN-(ben- 2-hydroxybenzamides 23a–g. The structures of the newly zyl carbamothioyl)-2-hydroxybenzamides 13a, b, f, and g preparedsubstitutedureacompounds23a–gwereconfirmed 1 13 were then cyclised by refluxing in acetic acid for 2 hours usingIRand Hand CNMRspectroscopyandmicroanal- 1 according to the general procedure D (Scheme3) and gave ysis. The H NMR and IR spectra supported the proposed thecorresponding2-benzylamino-1,3-benzoxazines15a,b,f, structuresandshowedsomecorrelationwiththepreviously andgfairtogoodyields. prepared benzyl thiourea 13a–q, 20a, c, and 21. In the 1H Previouslyprepared2-benzylamino-1,3-benzoxazine15a spectra, the methylene CH2 (H-11 of compounds 23a–g) of was characterized by comparison of the physical data (mp, the benzyl amine appears to shift up field as a doublet at IR, and 1H and 13C NMR spectra) with that found in the ∼𝛿4.3ppm.TheNH(H-10ofcompounds23a–g)appearsas 6 InternationalJournalofMedicinalChemistry R O R OH O 14a, b, and d-g10%HCL PhCH2NH2 H H NH N N O O O Ph 22 23 aR=H eR=7-OH aR=H eR=4-OH,3-CH3 bR=8-CH3 fR=7-OH,8-CH3 bR=3-CH3 fR=AcNH- cR=7-OCH3 gR=AcNH cR=4-OCH2CH3 gR=NH2 dR=7-OCH2CH3 hR=NH2 dR=4-OH CH3 CH3 S O O S O O O O 18c 10%HCL N N HN NH O O O O 24 25 PhCH NH 2 2 CH H 3 H N O O N N N O O 26 Scheme5:Synthesisof2-dione-1,3-benzoxazines22a–Iand25a,bfromthe2-methylthio-1,3-benzoxazines14a,b,d–g,and24a-b. abroadtripletat∼𝛿8.5ppm.The1Hand13CNMRspectra potentiallypathogenictohumansandanimalsandothersare oftheparent2-oxo-1,3-benzoxazines22and25. problematic in an environmental setting. Furthermore, the bacterial species selected have different cell wall composi- tions,thatis,someareGram-negativeandsomeareGram- 2.2.BiologicalTesting positivestrains.Someantimicrobialagentsinhibitbacteriaby 2.2.1.BrothDilutionSusceptibilityTesting. Inthisstudy,some interactingwithcomponentsofthecellwallthatareabsent of the newly prepared compounds were tested and showed in Gram-negative bacteria [37]; therefore, the selection of antimicrobial activity against 8 different bacterial strains strains was carefully selected with the possibility that an and 4 cultures of fungi. The bacterial species investigated inhibitory compound would also hint to its mechanism of were P. aeruginosa, B. subtilis, S. aureus, A. baumannii, E. action. Based on the results obtained it is clear that the coli, S. agalactiae M. smegmatis, and M. chlorophenolicum. Gram-negative strains, that is, P. aeruginosa, E. coli, and A. The antifungal evaluation was determined against A. niger, baumanniiwere least affectedbythecompoundsandwhen A. corymbifera, R. oryzae, and A. alternata. The minimal inhibitionwasobserveditwasathighlevels200𝜇gmL−1 or inhibitory concentrations (MICs) and minimal fungicidal higher. Interestingly, compound 9d seemed to have a more concentrations(MFCs),definedasthelowestconcentration dramatic effect Gram-positive strains with the exception of of drug that inhibits the growth of bacteria or fungi in the M.smegmatis.Despitetheeffectsthatsomeofthecompounds inoculums’,weredeterminedusingthebrothdilutionmeth- hadonthebacterialstrains,itappearsthatthesecompounds ods. The compounds which demonstrated MIC and MFC are not so effective when tested on the four fungal cultures valueslessthan300and200𝜇gmL−1,respectively,arelisted chosenwiththeexceptionof 9donA.corymbifera. inTables1and2.Accordingto[36],antimicrobialagentsare Based on the results obtained for each of the newly effectiveonarangeofbacterialspeciesatlowconcentrations, synthesisedcompounds,itisevidentthatcompound9dhas that is, <128𝜇gmL−1. Therefore, we conducted our MIC morepotenteffectwhencomparedtotheothers.Thisreveals experimentsusingconcentrationsashighas300𝜇gmL−1.We thatdespitethefactthatmostofthecompoundsdonotseem also selected a range of bacterial and fungal species to test tohaveanoteworthyeffectonthestrains,compound9disof our newly synthesised compounds. Some of the species are interestandfurtherinvestigationisrequired. InternationalJournalofMedicinalChemistry 7 Table1:BrothdilutionsusceptibilityMICvaluesforinhibitiongrowthofbacteria(𝜇gmL−1). Bacteria # P.aeruginosa B.subtilis S.aureus A.baumannii E.coli S.agalactiae M.smegmatis M.chloro 9c 200 200 >200 200 200 n/a >200 50 9d 200 100 25 200 200 n/a >200 25 13c >300 >300 >300 >300 >300 >300 n/a n/a 13d 200 >300 >300 200 >300 300 n/a n/a 13e >300 >300 300 >300 >300 >300 n/a n/a 13g >300 >300 >300 >300 >300 >300 n/a n/a 13j >300 >300 >300 >300 >300 200 n/a n/a 13l >300 >300 300 >300 >300 >300 n/a n/a 13m 200 200 300 >300 >300 >300 n/a n/a 13n 300 >300 300 300 >300 300 n/a n/a 20a >200 12.5 >200 >200 >200 n/a >200 >200 20c >200 25 >200 >200 >200 n/a >200 >200 21 >200 25 200 >200 >200 n/a 100 50 22g 200 >200 >200 200 >200 n/a >200 200 Table 2: Broth dilution susceptibility MFC values for inhibition listedinTables3and4andweretestedinduplicatewiththe growthoffungi(𝜇gmL−1). averagegiven.Anyzoneofinhibitionthatwasnotedaround thediscwasconsideredsensitiveandthezoneofclearlywas Fungi noted.Theseresultsaremoreusefulforcompoundsthatwere # R.oryzae A.niger A.corymbifera A.alternata difficult to dissolve, but equally, these results can indicate 9c 200 >200 >200 >200 resistanceifthecompounddoesnotdiffusethroughtheagar 9d 200 >200 100 >200 properly. 22g >200 >200 >200 >200 Based on the results obtained in Section2.2.1, it is clear 20a >200 >200 >200 >200 thatcompound9disofinterest.Basedontheresultsobtained 20c >200 >200 >200 >200 in Table3, compound 9d has an inhibitor effect on M. 21 >200 >200 200 200 smegmatis but in the MIC study had no effect. This could indicate solubility problems with the compound when in solution; however, this is only speculative; further studies are required to reveal the cause. In addition, compound 2.2.2. Disc Diffusion Susceptibility Testing. Disc diffusion 9d seems to have no inhibitory effect on S. aureus but in susceptibility testing was performed on compounds with the MIC studies had a dramatic affect. This difference in poor solubility in broth dilution susceptibility testing. The resultisunusualbutclearlyindicatesthatdifferentmethods preliminary antimicrobial testing was achieved using the couldrevealdifferentresultsandthereforeitisimportantto standard agar disk diffusion methods. Compounds that performbothmethodspriortofurtherinvestigationontheir inhibitedcertainbacteriaorfungiaresummarizedin(Tables inhibitoryeffects. 3and4). IntheMICstudies,weused300𝜇gmL−1 asthehighest The concentrations of the prepared compounds were 10−4𝜇gmL−1 (seeExperimental).Thecontroldataisusedto cut-off level. If a compound has an inhibitory effect on any strain that is greater than this level, then this should determineifthebacterialstrainsareresistant(R)orsensitive be revealed in the disc diffusion assay. However, further (S) to the prepared compounds tested. The disc diffusion investigation is required as some of these compounds are assaywasusedasapreliminaryguideforallcompoundsand dissolved in DMSO and when applied to bacterial cultures usedincorrespondencewiththebrothdilutionmethodfor determining MIC/MFC values. This method is particularly cancomeoutofsolution.Thediscdiffusionassaysseem to useful when MIC/MFC values are unable to be determined indicate some sensitivity to fungal cultures despite the fact using the broth dilution method due to the compounds thattheywereundetectableintheMICstudies. insolubility. The insoluble compounds zones of inhibition therefore can be determined in millimeters relative to the 2.3. The Structure Activity Relationships of the Tested Com- controlandusedasaroughguide.Sincethezoneofinhibition pounds(BrothDilution). TheresultsinTables1and2show ofclearancemaybeaffectedbyotherparameters,suchas,the that the 4-(benzylamino)-2-hydroxybenzoic acid derivative nutrientagardepthoftheplateandsolventused,theresults 9dshowedthebroadestrangeofactivityofthecompounds shownusingthismethodthereforeshouldbeusedasaguide. tested, exhibiting activity against the Gram-positive and MIC/MFC values are determined using the broth dilution Gram-negativebacteriaandalsoM. chlorophenolicum.Fur- method. All compounds that showed clearance zones are thermore, compound 9d showed to be more active than 8 InternationalJournalofMedicinalChemistry Table3:ResultsshowingDiscdiffusionsusceptibilityforthesynthesisedcompounds. Bacteria # P.aeruginosa B.subtilis S.aureus A.baumannii E.coli S.agalactiae M.smegmatis M.chloro 8c S(2mm) R R R R n/a S(2mm) R 8d S(2mm) S(3mm) R R R n/a S(2mm) S(2mm) 9c S(2mm) S(2mm) R R R n/a S(2mm) S(2mm) 9d S(2mm) S(4mm) R R R n/a S(2mm) S(2mm) 13b R S(6mm) S(5mm) R R S(5mm) n/a n/a 13k R S(2mm) S(5mm) S(2mm) R S(5mm) n/a n/a 13f R S(2mm) S(5mm) S(2mm) R S(5mm) n/a n/a 15d R S(2mm) S(5mm) S(2mm) R S(5mm) n/a n/a 15e R R R R R R n/a n/a 13o R R R R R — R R 13p R R R R R n/a S(2mm) R 13q R R R R R n/a R R 20a R S(2mm) R R R n/a R R 20c R S(2mm) R R R n/a S(3mm) S(4mm) 21 R S(4mm) R R R n/a R R 22h R R R R R n/a S(3mm) S(3mm) 22i R R R R R n/a S(2mm) R 23g R R R R R n/a R R Table 4: Disc diffusion susceptibility for the synthesised com- clearing was greater than the control which was indicative pounds. that the strain was sensitive to the compound, whereas a zoneofclearingequaltothecontrolindicatedresistance.The Fungi resultsrevealthatnoneofthecompoundshadaninhibitory # R.oryzae A.niger A.corymbifera A.alternata effect on E. coli at concentration 104𝜇gmL−1 (Table3). The 8c R R R R B. subtilis bacterial species tested showed inhibitory effects 8d S(2mm) S(3mm) S(5mm) R tomostofthecompoundstested,forexample,13dinhibited 9c R R R R S. aureus most strongly and compounds 13k, 13f, and 13d 9d R R R R inhibitedgrowthofA.baumannii,B.subtilis,andS.agalactiae 13p S(2mm) R R R (Table3). Some bacterial species that were sensitive to a 13q S(2mm) S(2mm) S(3mm) R 21c S(2mm) S(2mm) S(3mm) R compound showed similar sized zones of inhibition. One 20a R R R R example was 13k which exhibited activity of 2mm for A. 20c R R R R baumannii and B. subtilis and 5mm for S. aureus and S. 22h R R R R agalactiae. The same applies to compounds 8d, 9c, and 9d 22i R R R R whichhadshowna2mmclearancezoneagainstP.aeruginosa 25b R R R R M. smegmatis M. chlorophenolicum. Similarly to the broth dilution results, compounds 21 and 9d were found to be activeagainstthreefungispecies,R.oryzae,A.niger,andA. others against S. aureus with an MIC value of 25𝜇g/mL. corymbifera,withclearancezones2–5mm,respectively. Compounds20a,cand21(bis-thioureaproducts)werefound All the compounds tested showed a 2–4mm zone of to be particularly active towards Gram-positive B. subtilis clearingformostofthesusceptiblespecieswiththeexception at MIC values of 12.5, 25, and 25𝜇gmL−1. In addition, ofcompound13bwhichhadalarger6mmzoneofinhibition. compound 21 also showed activity towards M. smegmatis This larger zone indicates a hypersensitive effect on the (MIC 50𝜇gmL−1). Other synthesized compounds which bacterialspecies;however,itisspecificforthecompoundand showedaninhibitoryeffectwere13nwhichhadaninhibitory species.Becausethemechanismofactionofthecompound effect on four bacterial species at 300𝜇gmL−1 and 13d and is unknown, it is difficult to explain the reason for the 13m which had an inhibitory effect on two of the bacterial hypersensitive effect. One possible explanation is that B. species at concentration 200𝜇gmL−1. Interestingly, E. coli subtilisencodesaproteinthatcantransportcompound13b wasnotinhibitedbyanyofthecompounds. into the cell and this has a more toxic effect than those working from outside the cell. A similar phenomenon has 2.4. The Chemical Compounds Activity and Structural Rela- been shown with bacterial mercury resistance where the tionships of the Antimicrobial Assay Results (From Disk Dif- presenceofamercuryimportproteindisplaysalargerzone fusion Assay). In the presence of a compound, a zone of ofclearinginadiscdiffusionassay[38]. InternationalJournalofMedicinalChemistry 9 The data obtained revealed patterns of inhibition, espe- 0.01mol) was allowed to react with 4-amino-2-hydroxy- cially those conducted with the disc diffusion assay. This benzoic acid 7 (1.53g, 0.01mol) for 1 hour according to suggeststhatasimilarmechanismofactioncouldbeinvolved the reported procedure [29, 30] and gave solid which intheinhibitionofgrowth. recrystallised from methanol to give 8d 2.95g, 98% as red crystals, mp 185–188∘C decomp. ]max (KBr)/cm−1 1655 1 3.Conclusion (C=O), 1622, 1600 (C=N): HNMR (200MHz, 300K, d6- acetone)𝛿8.93(s,1H,H-8),8.02(d,1H,JH6,H5=8.8Hz,H-6), In conclusion, we have prepared seven new compounds of 7.33 (dd, 1H, JH15,H14 = 7.8Hz, JH15,H13 = 1.6Hz, H-15), 7.24 2-benzylamino-substituted-1,3-benzoxazines, nineteen new (dd,1H,JH13,H14 =8.0Hz,JH13,H15 =1.6Hz,H-13),6.91–7.09 N-(benzyl carbamothioyl)-substituted-benzamide and have (m, 3H, H-3,H-5, and H-14), 4.24 (q, 2H, JH16,H17 = 7.0Hz, evaluated some for their activity against bacteria and H-16), 1.41 (t, 3H, JH17,H16 = 7.0Hz, H-17). Product 8d was fungi.ItappearsthatN-(benzylcarbamothioyl)-substituted- usedimmediatelyinthesynthesisof 9d. benzamidehasshownantibacterialactivitysuchas20a,20c, 21,13d,13m,and13n. We are in the process of synthesising new substituted 4.1.4.Synthesisof4-Substituted-(benzylamino)-2-hydroxyben- products by replacing the benzyl group of N-(benzyl car- zoicAcids9a–d bamothioyl)by6-aminopenicillanicacidandtesttheirbac- General Procedure A. In slight modification to a previous teriaactivity. reported method, [28] the appropriate 4-substituted ((ben- zylidene) amino)-hydroxybenzoic acids 8b-c reduced using 4.Experimental sodiumborohydride(2equiv). 4.1.Chemistry. InfraredspectrawereobtainedusingaPerkin 1 13 4-(Benzylamino)-2-hydroxybenzoic Acid 9a. 2-Hydroxy-4- Elmer FT-IR 1720x spectrometer. H NMR and C NMR {[(𝐸)-benzylidene] amino}benzoicacid8b(2.41g, 10mmol) spectra were obtained using a Bruker AC 200 NMR spec- 1 was allowed to react with sodium borohydride (0.76g, trometerat200and50MHz,respectively.All HNMRand 13 20mmol) according to general procedure A. The resulting C NMR spectral results are recorded as chemical shifts solid was recrystallised from methanol/water to give 9a (in𝛿)CrDelaCtli3vesotolvetnhteainntder3n9a.l4TppMmS ifnorDpMroStoOn-da6ndsol7v7e.0ntppfomr (1.76g,73%),mp122–125∘C.]max (KBr)1/cm−1 3500–3200br 13 (OH), 3024, 2569 (NH), 1632(C=O); HNMR (200MHz, C NMR. Microanalysis was performed by Chemical and Micro analytical Services (CMAS), Australia. Melting point 340Kd6-DMSO)𝛿11.34(bs,1H,OHofCOOHexchangeable determinations were carried out using a Stuart Scientific withD2O),7.5(d,1H,JH6,H5=8.6Hz,H-6),7.21–7.47(m,6H, (SMP3) melting point apparatus and all melting points are 5xCH,8-NHexchangeablewithD2O),6.22(dd,1H,JH5,H6= uncorrected. 8.6Hz,JH5,H8=2.0Hz,H-5),6.03(d,1H,JH3,H5=2.0Hz,H- 3),4.38(s,2H,H-9).3.32(2-OHunderthewaterenvelope); 13CNMR(50MHz,340K,d6-DMSO)𝛿171.7(C-7),163.2(C- 4.1.1. Starting Materials. The stating reagents benzyl amine, 2),154.8(C-4),139.1(C-10),130.1(C-6),128.1,126.9,126.6(C- sodiumhydrogencarbonate,methyliodide-amino-2-hydro- 12, C-11 and C-13), 105.3 (C-5), 100.4 (C-1), 96.8 (C-3), 45.8 xybenzoic acid, and dry 1,4-dioxane were purchased from (C-9).Theresultingproduct9awasnotstableandwasused AldrichChemicalCompanyandwereusedasreceived. immediatelyinthegenralprocedureB. 4.1.2. Synthesis of 4-(Acetyl amino)-2-hydroxybenzoic Acid 2-Hydroxy-4-((2-hydroxybenzyl)amino)benzoicAcid9b.(E)- 8a. According to the previously reported method [29, 30, 2-Hydroxy-4-((2-hydroxybenzylidene)amino)benzoic acid 37], product 8a was prepared from the reaction of 4- 8c(2.6g,10mmol)wasallowedtoreactwithsodiumboro- amino-2-hydroxybenzoic acid 7 and acetic anhydride and hydride(0.76g,20mmol)accordingtogeneralprocedureA. ∘ recrystallisedfrom1,4-dioxane,82%yield,mp221–224 C(lit The resulting solid was recrystallised from methanol/water ∘ [37] and mp 235 C). The physical and spectroscopic data is ∘ to give 9b as white crystals (2.20g, 85%), mp 184–186 C consistentwiththeliteraturevalues[27,35]. decomp. ]max (KBr)/cm−1 3500–3200br (OH), 1614 (C=O); 1HNMR(200MHz,300Kd6-DMSO)𝛿11.45(bs,1H,8-NH 4.1.3.Synthesisof4-Substituted((Benzylidene)amino)-2-hyd- or 11-OH exchangeable with D2O), 9.61 (bs, 1H, 11-OH or roxybenzoicAcidIntermediates8b–e. Accordingtothepre- 8-NH exchangeable with D2O) 7.44 (d, 1H, JH6,H5 = 8.8Hz, viously reported method [29, 30], intermediates 8b–e were H-6),7.1–6.7(m,6H,H-13,H-15,H-14,H-12and11-OH),6.28 preparedfromtheappropriatesubstitutedbenzaldehydeand (dd, 1H, JH5,H6 = 8.8Hz, JH5,H3 = 1.1Hz, H-5), 5.92 (d, 1H, 4-amino-2-hydroxy-benzoicacid7. JH3,H5 =1.1Hz,H-3);13CNMR(50MHz,350K,d6-DMSO) Products 8b, c, and e were not identified and used 𝛿171.9(C-7),163.5(C-2),155.2/155.0(C-11/C-4),131.2(C-6), immediatelyinthesynthesisofcompound9a,b,andd. 128.5 (C-13), 127.9 (C-14), 125.0 (C-10), 119.1 (C-15), 115.3 (C-12), 105.6 (C-5), 100.6 (C-1), 97.0 (C-3), 41.1 (C-8). The (Z)-4-((3-Ethoxy-2-hydroxybenzylidene)amino)-2-hydroxy- resulting product 9b was used immediately in the general benzoic Acid 8d. 3-Ethoxy-2-hydroxybenzaldehyde (1.66g, procedureB. 10 InternationalJournalofMedicinalChemistry 4-((3-Ethoxy-2-hydroxybenzyl)amino)-2-hydroxybenzoic dryDCM(20mL)wasaddedtoamixtureoffreshlyprepared Acid 9c.(E)-4-((3-Ethoxy-2-hydroxybenzylidene)amino)-2- Ph3P(SCN)2 (10mmol) according to the general procedure hydroxybenzoic acid 8d (10mmol, 3.0g) was allowed to B. The resulting solid was isolated upon evaporation of the reactwithsodiumborohydride(20mmol,0.76g)according DCM filtrate 10b (0.74g, 91% crude yield). The solid was togeneralprocedureA.Theresultingsolidwascollectedand recrystallised from methanol, mp 250–253∘C decomp. ]max recrystallised from methanol/water to give 9d (2.66g, 81%) (KBr)cm−13443,3328,(NH2),3059,2916(NH),1749(C=O), as white crystals, mp 159–161∘C decomp. ]max (KBr)/cm−1 1679,1616(C=C),1205(C=S);1HNMR(200MHz,370K,d6- 3500–3200br(OH,NHabsorptionundertheOHenvelope), DMSO) 𝛿 13.04 (s, 1H, 3-NH), 7.58 (d, 1H, JH5,H6 = 8.6Hz, 1625(C=O);1HNMR(200MHz,300Kd6-DMSO)𝛿7.38(d, H-5), 6.65 (s, 2H, 7-NH2), 6.60 (dd, 1H, JH6,H5 = 8.6Hz, 1H,JH6,H5 =8.6Hz,H-6),6.85–6.65(m,3H,H-13,H-14and JH6,H8 =1.8Hz,H-6),6.37(d,1H,JH8,H6 =1.8Hz);13CNMR H-15), 6.35 (bs, 4H, 3 x OH and NH), 6.17 (dd, 1H, JH5,H6 (50MHz,330K,d6-DMSO)𝛿182.4(C-2),157.3,156.9,156.5 = 8.6Hz, JH5,H3 = 1.8Hz, H-5), 5.87 (d, 1H, JH3,H5 = 1.8Hz, (C-4, C-8a, C-7), 128.1 (C-5), 112.7 (C-6), 102.3 (C-4a), 96.8 H-3), 4.23 (s, 2H, CH2NH, H-9), 4.05 (q, 2H, JH16,H17 = (C-8); Anal. Calcd. For C8H6N2O2S: C, 49.47; H, 3.11; N, 13 6.8Hz,H-16),1.35(t,3H,JH17,H16=6.8Hz,H-17); CNMR 14.42.Found:C,49.51;H,3.20;N,14.36. (50MHz,300K,d6-DMSO)𝛿172.2(C-7),163.6(C-2),155.3 (C-4), 146.6 (C-12), 144.1 (C-11), 131.4 (C-6), 125.7 (C-10), 7-(Benzylamino)-2-thioxo-2H-benz[e][1,3]oxazin-4(3H)-one 120.3(C-14),119.2(C-15),111.8(C-13),105.8(C-1),100.2(C-5), 11a. In slight modification to previously reported general 96.7(C-3),64.4(C-16),40.8(C-9),15.0(C-17);Anal.Calcd. procedure B, 4-(benzylamino)-2-hydroxybenzoic acid 9a ForC16H17NO5:C,63.36;H,4.62;N,5.65.Found:C,63.51; (0.94g, 4mmol) was allowed to react with the freshly H,4.48;N,5.66. prepared Ph3P(SCN)2 (10mmol) at room temperature for 2 hours then under reflux for 16 hours. The resulting crude 4.1.5. Synthesis of Substituted-dihydroxy-di-carboxylic Acids solids(0.94g,82%)werefiltered,collected,andrecrystallised 16 and 17. According to the previously reported general fromtoluenetogive11a(0.88g,77%)asyellowcrystals,mp procedures[23–26], theappropriatesubstitutedphenol was 210–212∘Cdecomp.]max(KBr)/cm−13301(9-NH)3068,2926 used in the synthesis substituted-dihydroxy-di-carboxylic 1 (3-NH),1689(C=O),1197(C=S); HNMR(200MHz,340K, acids16and17. d6-DMSO) 𝛿 12.90 (bs, 1H, 3-NH exchangeable with D2O), 4.1.6.Synthesisof7-N-Substituted-amino-1,3-oxazines10a,b, 7.61 (d, 1H, JH5,H6 = 8.8Hz, H-5), 7.37–7.26 (m, 6H, Ar and 9-NHexchangeablewithD2O),6.73(dd,1H,JH6,H5=8.8Hz, and11a,b,andd JH6,H8=2.0Hz,H-6),6.42(d,1H,JH8,H6=2.0Hz,H-8),4.41 13 GeneralProcedureB.Thesubstituted-2-hydroxybenzoicacid (d, 2H, JH10,H9 = 5.9Hz, H-10); C NMR (50MHz, 340K, was allowed to react with the freshly prepared Ph3P(SCN)2 d6-DMSO)𝛿182.1(C-2),157.2,156.5(C-4,C-8a),155.2(C-7), accordingtopreviouslyreportedgeneralprocedure[22,34]. 138.2(C-11),(128.2,127.3,127.0,126.8),(C-13,C-12,C-14and C-5),111.9(C-6),102.5(C-4a),95.1(C-8),45.8(C-10);Anal. N-(4-Oxo-2-thioxo-3,4-dihydro-2H-benz[e][1,3]oxazin-7-yl) Calcd.ForC15H12N2O2S:C,59.99;H,4.03;N,9.33.Found: acetamide 10a. Slightly modified to the previously reported C,59.83;H,4.14;N,9.45. general procedure B [22, 34], 4-(acetyl amino)-2- hydroxybenzoic acid 8a (1.56g, 8mmol) was allowed to 7-((2-Hydroxybenzyl)amino)-2-thioxo-2H-benz[e][1,3]oxaz- reactwithfreshlypreparedPh3P(SCN)2 (10mmol)atroom in-4(3H)-one 11b. In slight modification to previously temperature for 2 hours then under reflux for 16 hours. reportedgeneralprocedureB,2-hydroxy-4-((2-hydroxyben- At the completion of the reaction, the PbBr2 filter cake zyl)amino)benzoic acid 9b (1.07g, 4mmol) was allowed to was washed by acetic acid (150mL) to extract the desired react with the freshly prepared Ph3P(SCN)2 (10mmol) at product.Theaceticacidfiltratewasevaporatedandminimal roomtemperaturefor2hoursthenunderrefluxfor16hours. toluenewasaddedtodissolveanyoilwiththeproduct.The The resulting crude solid recrystallised from acetonitrile ∘ crude solid was filtered and recrystallised from ethanol to to give 11b (0.55g, 46%) as yellow crystals, mp 173–175 C give 10a (1.22g, 65%) as light red crystals, mp 285–287∘C decomp.]max(KBr)/cm−13500–3000br(OH),3310(9-NH), decomp. ]max (KBr)/cm−1 3290, 3183 (9-NH), 3072, 2923 2926 (3-NH), 1684 (C=O), 1192 (C=S); 1HNMR (200MHz, (3-NH),1704(C=O),1188(C=S);1HNMR(200MHz,390K, 340K, d6-DMSO) 𝛿 12.86 (bs, 1H, 3-NH), 9.50 (bs, 1H, d6-DMSO)𝛿13.38(bs,1H,9-NH),10.56(s,1H,3-NH),7.86 12-OH), 7.59 (d, 1H, JH5,H6 = 8.6Hz, H-5), 7.41 (bs, 1H, (d, 1H, JH5,H6 = 8.6Hz, H-5), 7.77 (d, 1H, JH8,H6 = 1.8Hz, 9-NH), 7.05–7.20 (m, 2H, H-14, H-16), 6.69–6.88 (m, 3H, H-8), 7.44 (dd, 1H, JH6,H5 = 8.6Hz, JH6,H8 = 1.8Hz, H-6), H-13,H-15andH-6),6.42(d,1H,JH8,H6=2.0Hz,H-8),4.32 2.11 (s, 3H, 11-CH3); 13C NMR (50MHz, 330K, d6-DMSO) (s,2H,H-10);13CNMR(50MHz,340K,d6-DMSO)𝛿182.2 𝛿 181.9 (C-2), 169.2 (C-10), 156.7 (C-8a), 146.0 (C-7), 127.3 (C-2), 157.3, 156.7, 155.4, 154.9 (C-4, C-8a, C-12 and C-7), (C-5),116.3(C-6),109.6(C-4a),104.2(C-8),24.0(C-11)155.9 128.5, 127.9, 127.3 (C-14, C-16 and C-5) 123.9 (C-11), 118.8, (C-4); Anal. Calcd. For C10H8N2O3S: C, 50.84; H, 3.41; N, 115.1 C-15, C-13), 111.9 (C-6), 102.2 (C-4a), 94.9 (C-8), 40.9 11.86C.Found:C,50.69;H,3.53;N,11.86. (C-10); Anal. Calcd. For C15H12N2O3: C, 59.99; H, 4.03; N, 9.33Found:C,59.83;H,4.14;N,9.45. Synthesisof7-Amino-2-thioxo-2H-benz[e][1,3]oxazin-4(3H)- one10b.Asuspensionof(E)-4-((3-ethoxy-2-hydroxybenzy- 7-((3-Ethoxy-2-hydroxybenzyl)amino)-2-thioxo-2H-benz[e] lidene)amino)-2-hydroxybenzoic acid 8d (1.2g, 4mmol) in [1,3]oxazin-4(3H)-one 11c. In slight modification to

Description:
activity, the imide linker (preferred) or urea linker retains hyde gave the corresponding Schiff base 8b-c (Scheme 2) Aldrich Chemical Company and were used as received. prepared from the appropriate substituted benzaldehyde and . hydroxybenzoic acid 8d (10mmol, 3.0g) was allowed to.
See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.